Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Guardant Health, Inc. - Common Stock (NQ:GH)

111.03 +9.16 (+9.00%)
Streaming Delayed Price Updated: 2:29 PM EST, Jan 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Guardant Health, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
News headline image
Is Guardant Health Inc Gaining or Losing Market Support? ↗
 
Via Benzinga
News headline image
Guardant Health and Collaborators to Present New Data Across the Cancer Care Continuum at ESMO 2025
From Guardant Health, Inc.
Via Business Wire
News headline image
Guardant Health to Report Third Quarter 2025 Financial Results on October 29, 2025
From Guardant Health, Inc.
Via Business Wire
News headline image
1 Volatile Stock to Research Further and 2 Facing Headwinds
A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south. While some investors embrace risk, mistakes can be costly for those who aren’t prepared. 
Via StockStory
Topics Initial Public Offering
News headline image
What Does the Market Think About Guardant Health Inc? ↗
 
Via Benzinga
News headline image
Decoding Life's Blueprint: New Tech Maps RNA-Protein Interactions, Unlocking Disease Cures
A monumental leap in biomedical research has been announced with the development of a breakthrough technology capable of mapping the entire intricate network of RNA-protein interactions within human... 
Via MarketMinute
Topics Artificial Intelligence Derivatives
News headline image
Stocks making big moves yesterday: Beyond Meat, The Trade Desk, Guardant Health, PayPal, and Tilray
Check out the companies making headlines yesterday: 
Via StockStory
Topics Cannabis Government
News headline image
Why Guardant Health (GH) Stock Is Trading Up Today
Shares of diagnostics company Guardant Health (NASDAQ:GH) jumped 1.6% in the morning session after the U.S. Food and Drug Administration (FDA) approved its Guardant360® CDx blood test as a companion... 
Via StockStory
News headline image
FDA Approves Guardant360® CDx as Companion Diagnostic for Eli Lilly and Company’s Inluriyo™ (imlunestrant) for Treatment of ESR1-mutated Advanced Breast Cancer
From Guardant Health, Inc.
Via Business Wire
News headline image
Guardant Health (GH) Stock Trades Up, Here Is Why
Shares of diagnostics company Guardant Health (NASDAQ:GH) jumped 5.2% in the morning session after the company announced a collaboration with Quest Diagnostics and provided an upbeat financial outlook... 
Via StockStory
Topics Artificial Intelligence
News headline image
Guardant Health and Quest Diagnostics Announce Strategic Collaboration to Broaden Access to Guardant’s Shield™ Blood-based Screening Test in the United States
From Guardant Health, Inc.
Via Business Wire
News headline image
3 Reasons to Avoid GH and 1 Stock to Buy Instead
Guardant Health’s 28.8% return over the past six months has outpaced the S&P 500 by 13.3%, and its stock price has climbed to $60.20 per share. This was partly due to its solid quarterly results, and... 
Via StockStory
Topics Bankruptcy Stocks
News headline image
Guardant Health (GH) Stock Is Up, What You Need To Know
Shares of diagnostics company Guardant Health (NASDAQ:GH) jumped 1.2% in the afternoon session after multiple financial analysts issued positive ratings on the stock. Canaccord Genuity reaffirmed its... 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
3 Small-Cap Stocks We Approach with Caution
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside... 
Via StockStory
News headline image
Testing & Diagnostics Services Q2 Earnings: Guardant Health (NASDAQ:GH) is the Best in the Biz
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how testing & diagnostics services stocks fared in Q2, starting... 
Via StockStory
News headline image
Q2 Earnings Recap: Guardant Health (NASDAQ:GH) Tops Testing & Diagnostics Services Stocks
Looking back on testing & diagnostics services stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Guardant Health (NASDAQ:GH) and its peers. 
Via StockStory
News headline image
3 Unpopular Stocks with Warning Signs
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other... 
Via StockStory
News headline image
Alex M. Azar II Joins Guardant Health Board of Directors
From Guardant Health, Inc.
Via Business Wire
News headline image
Guardant Health Expands Access to Shield CRC Blood Test to Senior Living Communities with LabFlorida Partnership
From Guardant Health, Inc.
Via Business Wire
News headline image
Select Medical, Guardant Health, Artivion, PacBio, and Intuitive Surgical Shares Are Falling, What You Need To Know
A number of stocks fell in the afternoon session after markets pulled back, reversing early gains, as investor sentiment remained cautious despite a softer-than-expected inflation reading. 
Via StockStory
Topics Economy Stocks
News headline image
Guardant Health Announces Partnership with PathGroup Bringing Shield Blood Test to 250+ Hospitals and Health Systems in 25 States
From Guardant Health, Inc.
Via Business Wire
News headline image
Why Guardant Health (GH) Shares Are Plunging Today
Shares of diagnostics company Guardant Health (NASDAQ:GH) fell 7.1% in the morning session after the company announced updated clinical results for its Shield blood-based colorectal cancer screening... 
Via StockStory
Topics Economy
News headline image
Why IBD 50's Guardant Health Just Tumbled, Breaking A 67% Monthlong Run ↗
The company is working on a second version of its colon cancer screening test, Shield. 
Via Investor's Business Daily
News headline image
Guardant Health Announces Clinical Result Update for Shield Blood-Based Colorectal Cancer Screening Test
From Guardant Health, Inc.
Via Business Wire
News headline image
Guardant Health to Host Investor Day on September 24, 2025
From Guardant Health, Inc.
Via Business Wire
News headline image
Guardant Health to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
From Guardant Health, Inc.
Via Business Wire
News headline image
3 Cash-Burning Stocks Walking a Fine Line
Companies that burn cash at a rapid pace can run into serious trouble if they fail to secure funding. Without a clear path to profitability, these businesses risk dilution, mounting debt, or even... 
Via StockStory
Topics Bankruptcy
News headline image
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Guardant Health, Inc.
Via Business Wire
News headline image
Astrana Health, agilon health, Guardant Health, AdaptHealth, and Pediatrix Medical Group Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer... 
Via StockStory
Topics Economy Initial Public Offering
News headline image
GH Q2 Deep Dive: Strong Volume Growth and Product Expansion Amid Profitability Challenges
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.